title: Do patents prevent access to drugs for HIV in developing countries?
authors.forename: Eric
authors.initials: E
authors.lastname: Goemaere
authors.forename: Anne-Valerie
authors.initials: AV
authors.lastname: Kaninda
authors.forename: Laura
authors.initials: L
authors.lastname: Ciaffi
authors.forename: Maryline
authors.initials: M
authors.lastname: Mulemba
authors.forename: Ellen
authors.initials: E
authors.lastname: t Hoen
authors.forename: Bernard
authors.initials: B
authors.lastname: Pécoul
mesh_terms: D000349:Africa; D019380:Anti-HIV Agents / Q000191:economics / Q000600:supply & distribution*; D023241:Antiretroviral Therapy, Highly Active / Q000191:economics; D003906:Developing Countries; D004345:Drug Industry; D016568:Drugs, Generic; D010330:Patents as Topic
chemical_list: D019380:Anti-HIV Agents; D016568:Drugs, Generic